Catalysts for Cometriq
25 tracked
Apr 30, 2026
phase 1 completion
Takeda Pharmaceutical Co Ltd — Cabometyx (Phase I Trial Completion)
cabozantinib s-malate
→
Oct 9, 2025
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Oct 9, 2025
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Sep 10, 2025
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Mar 26, 2025
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Sep 20, 2023
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Aug 23, 2023
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Feb 13, 2023
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jul 14, 2022
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Sep 17, 2021
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jan 22, 2021
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Nov 5, 2020
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Oct 22, 2020
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jul 16, 2020
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jan 31, 2020
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jan 31, 2020
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jan 14, 2019
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Jan 12, 2018
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Dec 19, 2017
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Nov 16, 2017
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Oct 5, 2017
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
May 20, 2016
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Apr 25, 2016
approval
CABOMETYX (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Feb 28, 2014
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→
Nov 29, 2012
approval
COMETRIQ (CABOZANTINIB S-MALATE) — FDA approval
cabozantinib s-malate
→